A serious adverse event at an unregulated U.S. ketamine or psychedelic clinic will be cited in congressional hearing testimony or trigger a formal federal investigation within 12 months of today.

Someone will be seriously hurt or die at an unregulated ketamine or psychedelic clinic in the US, the story will get attention, and Congress or a federal agency will hold a public hearing or launch a formal investigation. This matters because ketamine clinics are booming but barely regulated, and one high-profile disaster could reshape the whole industry.

Ketamine clinic expansion is rapid and largely unregulated at the federal level. Matthew Perry's death from ketamine in 2023 already demonstrated celebrity-case dynamics. The probability of at least one high-profile adverse event is moderate; the probability that it reaches congressional testimony or formal federal investigation is lower but non-trivial given ongoing congressional interest in the space.